TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nigaard Pharma Oy
Closing information (x1000 SEK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
658
|
343 | |
| Financial expenses | 9 | ||
| Earnings before taxes |
-2,420
|
174
|
-761 |
| Total assets |
947
|
658
|
362 |
| Current assets |
851
|
0
|
19 |
| Current liabilities |
210
|
347
|
1,104 |
| Equity capital |
737
|
329
|
-733 |
| - share capital |
29
|
27
|
29 |
| Employees (average) |
1
|
1 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
77.8%
|
50.0%
|
-202.5% |
| Turnover per employee | 658 | ||
| Profit as a percentage of turnover |
26.4%
|
-221.9% | |
| Return on assets (ROA) | 27.8% | ||
| Current ratio |
405.2%
|
0%
|
1.7% |
| Return on equity (ROE) |
-328.4%
|
52.9%
|
103.8% |
| Change turnover | 329 | ||
| Change turnover % | 100% | ||
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.